FDA Device Intelligence
Home › STRECK, INC. › Cell-Free DNA BCT

Cell-Free DNA BCT

STRECK, INC. · Model 230469 · UDI-DI 10844509002250

QMA Prescription
1
510(k) clearances
0
Adverse events
0
Recalls
4
Facilities

Description

Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization, and transport of venous whole blood samples for use in conjunction with cell-free DNA next- generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.